Cargando…

“Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis.”

BACKGROUNDS AND AIMS: The role of hydroxychloroquine (HCQ) in the treatment of COVID-19 is not fully known. We studied the efficacy of HCQ compared to the control in COVID-19 subjects on - a. viral clearance measured by reverse transcriptase polymerase chain reaction (RT-PCR) and, b. death due to al...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Awadhesh Kumar, Singh, Akriti, Singh, Ritu, Misra, Anoop
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Diabetes India. Published by Elsevier Ltd. 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215156/ https://www.ncbi.nlm.nih.gov/pubmed/32417708 http://dx.doi.org/10.1016/j.dsx.2020.05.017

Ejemplares similares

Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Molnupiravir in COVID-19: A systematic review of literature
por: Singh, Awadhesh Kumar, et al.
Publicado: (2021)

Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

An updated practical guideline on use of molnupiravir and comparison with agents having emergency use authorization for treatment of COVID-19()
por: Singh, Awadhesh Kumar, et al.
Publicado: (2022)

Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India
por: Singh, Awadhesh Kumar, et al.
Publicado: (2021)

Role of corticosteroid in the management of COVID-19: A systemic review and a Clinician’s perspective
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Noninsulin‐based antihyperglycemic medications in patients with diabetes and COVID‐19: A systematic review and meta‐analysis
por: Nassar, Mahmoud, et al.
Publicado: (2023)

Prevalence of co‐morbidities and their association with mortality in patients with COVID‐19: A systematic review and meta‐analysis
por: Singh, Awadhesh K., et al.
Publicado: (2020)

Non-insulin anti-diabetic agents in patients with type 2 diabetes and COVID-19: A Critical Appraisal of Literature
por: Singh, Awadhesh Kumar, et al.
Publicado: (2021)

COVID-19: From bench to bed side
por: Singh, Akriti, et al.
Publicado: (2020)

Heart Failure Hospitalization with DPP-4 Inhibitors: A Systematic Review and Meta-analysis of Randomized Controlled Trials
por: Singh, Awadhesh Kumar, et al.
Publicado: (2019)

Letter in response to letter to the editor by Singh and Dhibar regarding the article “COVID-19: From bench to bedside” (Singh et al.)
por: Singh, Akriti, et al.
Publicado: (2020)

Editorial: Herd mentality, herds of migrants/people, and COVID-19 in India
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Impact of COVID-19 and comorbidities on health and economics: Focus on developing countries and India
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Letter to the editor in response to the article: “Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis (Kumar et al.)”
por: Kumar Singh, Awadhesh, et al.
Publicado: (2020)

Clinical considerations for patients with diabetes in times of COVID-19 epidemic
por: Gupta, Ritesh, et al.
Publicado: (2020)

Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Reply to the letter of Mahajan and Gaur in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.)
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Does poor glucose control increase the severity and mortality in patients with diabetes and COVID-19?
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19?
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

At-admission hyperglycemia is consistently associated with poor prognosis and early intervention can improve outcomes in patients with COVID-19
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Systematic review and meta-analysis of efficacy and safety of hydroxychloroquine and chloroquine in the treatment of COVID-19
por: Mittal, Niti, et al.
Publicado: (2021)

Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors combination therapy in type 2 diabetes: A systematic review of current evidence
por: Singh, Awadhesh Kumar, et al.
Publicado: (2016)

Letter by Awadhesh Kumar Singh Regarding Article, “Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylurea as Add-on Therapy for Type 2 Diabetes Mellitus: A Meta-Analysis”
por: Singh, Awadhesh Kumar, et al.
Publicado: (2022)

Comments on: Rise of the phoenix: Mucormycosis in COVID-19 times
por: Singh, Awadhesh K, et al.
Publicado: (2021)

Hydroxychloroquine and QTc prolongation in patients with COVID-19: A systematic review and meta-analysis
por: Agstam, Sourabh, et al.
Publicado: (2020)

Can anti-Mullerian hormone replace ultrasonographic evaluation in polycystic ovary syndrome? A review of current progress
por: Singh, Awadhesh Kumar, et al.
Publicado: (2015)

Recent cardiovascular outcome trials of antidiabetic drugs: A comparative analysis
por: Singh, Awadhesh Kumar, et al.
Publicado: (2017)

Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis
por: Elavarasi, Arunmozhimaran, et al.
Publicado: (2020)

Dipeptidyl peptidase-4 inhibitors or sodium glucose co-transporter-2 inhibitors as an add-on to insulin therapy: A comparative review
por: Singh, Awadhesh Kumar, et al.
Publicado: (2016)

Safety and Efficacy of Hydroxychloroquine in COVID-19: A Systematic Review and Meta-Analysis
por: Ullah, Waqas, et al.
Publicado: (2020)

The Outcome of Hydroxychloroquine in Patients Treated for COVID-19: Systematic Review and Meta-Analysis
por: Ayele Mega, Teshale, et al.
Publicado: (2020)

Efficacy and safety of hydroxychloroquine in osteoarthritis: a systematic review and meta-analysis of randomized controlled trials
por: Singh, Ambrish, et al.
Publicado: (2022)

Hydroxychloroquine and COVID-19 – A narrative review
por: Bajpai, Jyoti, et al.
Publicado: (2020)

Hydroxychloroquine use and progression or prognosis of COVID-19: a systematic review and meta-analysis
por: Zang, Yanxiang, et al.
Publicado: (2020)

Impact of Hydroxychloroquine on Mortality in Hospitalized Patients with COVID-19: Systematic Review and Meta-Analysis
por: Hong, Thomas S., et al.
Publicado: (2020)

Cardiac Toxicity of Chloroquine or Hydroxychloroquine in Patients With COVID-19: A Systematic Review and Meta-regression Analysis
por: Tleyjeh, Imad M., et al.
Publicado: (2020)

Systematic review and meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19
por: García-Albéniz, Xabier, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sh094sdeibueheicmishh18ud9